Nicotinamide Riboside Clinical Trial for GWI

NARecruitingINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

April 13, 2022

Primary Completion Date

April 30, 2025

Study Completion Date

December 31, 2025

Conditions
Gulf War Illness
Interventions
DIETARY_SUPPLEMENT

Nicotinamide Riboside

The product under investigation, Nicotinamide riboside (NR), is a naturally occurring NAD+ precursor and a member of the vitamin B3 family.

DIETARY_SUPPLEMENT

Placebo

Visually matching placebo capsules will contain the same inactive ingredients present in the manufactured NR capsules, with the exception of any NR compound.

Trial Locations (2)

33314

RECRUITING

Nova Southeastern University, Fort Lauderdale

34243

RECRUITING

The Roskamp Institute, Sarasota

All Listed Sponsors
lead

Roskamp Institute Inc.

OTHER

collaborator

United States Department of Defense

FED

collaborator

Nova Southeastern University

OTHER